financetom
Business
financetom
/
Business
/
Viridian Therapeutics' eye disorder drug meets late-stage study goal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Viridian Therapeutics' eye disorder drug meets late-stage study goal
Dec 16, 2024 4:23 AM

Dec 16 (Reuters) - Viridian Therapeutics ( VRDN ) said

on Monday its experimental drug to treat an immune system

disorder, chronic thyroid eye disease, met the main goal of a

late-stage study.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US safety board criticizes Boeing, FAA over 737 MAX 9 panel blowout
US safety board criticizes Boeing, FAA over 737 MAX 9 panel blowout
Jun 24, 2025
* NTSB criticizes Boeing's ( BA ) safety culture and FAA oversight * NTSB chair: 'It's nothing short of a miracle' that no fatalities, serious injuries * January 2024 incident led to criminal investigation and Boeing ( BA ) CEO's resignation (Rewrites with board meeting ongoing in paragraphs 1-5) By David Shepardson WASHINGTON, June 24 (Reuters) - A U.S. National...
Miata Metals Begins Drilling at Puma Target
Miata Metals Begins Drilling at Puma Target
Jun 24, 2025
10:57 AM EDT, 06/24/2025 (MT Newswires) -- Miata Metals ( MMETF ) , up 17% on last look from near 52 week lows, on Tuesday said it had begun its planned drill test of the Puma Target. This follows completion of the latest five holes drilled at the Golden Hand Target, for which assays are pending, it added. A statement...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
McCormick Set to Report 'Solid' Q2 Results, But Tariff Uncertainty Looms, UBS Says
McCormick Set to Report 'Solid' Q2 Results, But Tariff Uncertainty Looms, UBS Says
Jun 24, 2025
10:58 AM EDT, 06/24/2025 (MT Newswires) -- McCormick ( MKC ) is expected to report solid fiscal Q2 results, however, it's difficult to have confidence in any updates to full-year 2025 earnings per share guidance due to ongoing uncertainty around tariffs, UBS said in an earnings preview Monday. The food company is scheduled to report its Q2 results on Thursday,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved